dc.contributor.author | Abdel-Aal, Abu-Baker M. | |
dc.contributor.author | Zaman, Mehfuz | |
dc.contributor.author | Fujita, Yoshio | |
dc.contributor.author | Batzloff, Michael R. | |
dc.contributor.author | Good, Michael Francis | |
dc.contributor.author | Toth, Istvan | |
dc.date.accessioned | 2011-07-14 | |
dc.date.accessioned | 2017-03-01T21:59:23Z | |
dc.date.available | 2017-03-01T21:59:23Z | |
dc.date.issued | 2010 | |
dc.date.modified | 2011-08-12T06:20:28Z | |
dc.identifier.issn | 0818-9641 | |
dc.identifier.doi | http://dx.doi.org/10.1021/jm1007787 | |
dc.identifier.uri | http://hdl.handle.net/10072/39929.1 | |
dc.description.abstract | Immunological assessment of group A streptococcal (GAS) branched lipopeptides demonstrated the impact of spatial arrangement of vaccine components on both the quality and quantity of their immune responses. Each lipopeptide was composed of three components: a GAS B-cell epitope (J14), a universal CD4+ T-cell helper epitope (P25), and an immunostimulant lipid moiety that differs only in its spatial arrangement. The best systemic immune responses were demonstrated by a lipopeptide featuring the lipid moiety at the lipopeptide C-terminus. However, this candidate did not achieve protection against bacterial challenge. The best protection (100%) was shown by a lipopeptide featuring a C-terminal J14, conjugated through a lysine residue to P25 at the N-terminus, and a lipid moiety on the lysine side chain. The former candidate features α-helical conformation required to produce protective J14-specific antibodies. Our results highlight the importance of epitope orientation and lipid position in the design of three-component synthetic vaccines. | |
dc.description.peerreviewed | Yes | |
dc.description.publicationstatus | Yes | |
dc.language.iso | en_AU | |
dc.publisher | Nature Publishing Group | |
dc.publisher.place | United Kingdom | |
dc.relation.ispartofstudentpublication | N | |
dc.relation.ispartofpagefrom | 8041 | |
dc.relation.ispartofpageto | 8046 | |
dc.relation.ispartofissue | 22 | |
dc.relation.ispartofjournal | Journal of Medicinal Chemistry | |
dc.relation.ispartofvolume | 53 | |
dc.rights.retention | Y | |
dc.subject.fieldofresearch | Immunology not elsewhere classified | |
dc.subject.fieldofresearch | Biochemistry and Cell Biology | |
dc.subject.fieldofresearch | Immunology | |
dc.subject.fieldofresearchcode | 110799 | |
dc.subject.fieldofresearchcode | 0601 | |
dc.subject.fieldofresearchcode | 1107 | |
dc.title | Design of Three-Component Vaccines against Group A Streptococcal Infections: Importance of Spatial Arrangement of Vaccine Components | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dc.type.code | c1x | |
gro.faculty | Faculty of Science, Environment, Engineering and Technology | |
gro.date.issued | 2010 | |
gro.hasfulltext | No Full Text | |
gro.griffith.author | Good, Michael F. | |